Search
for
Sort by
Research 391–420 of 1000+
- Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Efficacy and safety of methotrexate in alopecia areata
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Androgenetic Alopecia: A Review
- Cosmetic Surgery Considerations in the Female Patient
- Drug-Induced Hair Disorders
- Drug-Induced Hair Loss and Hair Growth
- Assessment, diagnosis and treatment of a patient with hirsutism
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Cutaneous drug reactions
- Exploring Nanotechnology With Traditional Herbal Pharmacology: Nano Carrier-Based Phytochemical Delivery In PCOS Treatment
- Efficacy and Safety of Spironolactone in Acne Management
- New onset of alopecia in a young woman with end-stage renal disease
- Drug-induced changes in hair growth
- Implications of Non-compliance in the Management of Chronic Polycystic Ovarian Syndrome
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- Systematic approach to hair loss in women
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Drug Reactions Affecting Hair: Diagnosis
- Physiological Skin Changes During Pregnancy
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Effect of finasteride in idiopathic hirsutism
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- Testosterone Therapy in Premenopausal Women